Since elevated NCAPH levels mediate a poor response to chemotherapy in breast cancer patients and cells (Figure 1G,L–N), we evaluated the response of tumours generated in BX‐Neu+ mice to chemotherapy. This evidence concerns the gene ERBB2 and breast carcinoma.